MARKET

ANVS

ANVS

Annovis Bio Inc
NYSE
1.470
-0.080
-5.16%
After Hours: 1.540 +0.07 +4.76% 17:45 04/29 EDT
OPEN
1.570
PREV CLOSE
1.550
HIGH
1.610
LOW
1.450
VOLUME
188.61K
TURNOVER
0
52 WEEK HIGH
20.00
52 WEEK LOW
1.110
MARKET CAP
28.64M
P/E (TTM)
-0.7283
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ANVS last week (0421-0425)?
Weekly Report · 1d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 5d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 04/21 21:05
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 04/21 17:05
Weekly Report: what happened at ANVS last week (0414-0418)?
Weekly Report · 04/21 09:28
Weekly Report: what happened at ANVS last week (0407-0411)?
Weekly Report · 04/14 09:26
Weekly Report: what happened at ANVS last week (0331-0404)?
Weekly Report · 04/07 09:26
Weekly Report: what happened at ANVS last week (0324-0328)?
Weekly Report · 03/31 09:28
More
About ANVS
More
Annovis Bio, Inc. is a late-stage clinical drug platform company addressing neurodegeneration such as Alzheimer’s disease (AD), and Parkinson’s disease (PD). The Company is developing its lead product candidate, Buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Buntanetap is a synthetically produced small molecule, orally administered, brain penetrant compound. Its product candidate ANVS405 is an intravenous drug being developed for acute indications and focused on protecting the brain after traumatic brain injury and/or stroke. ANVS405 is the same compound as Buntanetap, given in cases of acute head and brain trauma. ANVS301 is an orally administered drug being developed to increase cognitive capability in later stages of AD and dementia. ANVS301 is observed to improve memory and learning in very old rats by lowering the number of errors from over six to three.
Recently
Symbol
Price
%Change

Webull offers Annovis Bio Inc stock information, including NYSE: ANVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANVS stock methods without spending real money on the virtual paper trading platform.